The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
© 2020-23 Digest Wire. All rights belong to their respective owners.
The FTC action would target often high costs by trying to curb rebates it says drug makers pay to steer patients to their brand name products.
Both sides are desperate for three points in this match.
DigestWire is an automated news feed that utilizes AI technology to gather information from sources with varying perspectives. This allows users to gain a comprehensive understanding of different arguments and make informed decisions. DigestWire is dedicated to serving the public interest and upholding democratic values.
Privacy Policy Terms and Conditions
© 2023 Digest Wire - All right reserved.